What topical agents can be used to control bleeding?

Topical Hemostatic Agents for Bleeding Control

For active bleeding control, use topical vasoconstrictors (oxymetazoline), tranexamic acid, or cautery as first-line interventions, with biologic hemostatic agents (fibrin sealants, thrombin, gelatin, collagen, oxidized cellulose) reserved for surgical settings where electrocautery or sutures are not feasible.

Immediate Bleeding Control Agents

Vasoconstrictors

• Oxymetazoline (Afrin) provides rapid control of active bleeding through direct application via nasal spray or cotton pledgets inserted into the bleeding site 1
• These agents work immediately by constricting blood vessels at the bleeding site 1
• Caution: Repeated use can cause rhinitis medicamentosa, excessive nasal dryness, and may worsen hypertension or glaucoma 1
• Should not be used for more than 3-5 days consecutively to avoid rebound congestion 1

Tranexamic Acid (TXA)

• Topical TXA is an inexpensive antifibrinolytic agent that provides superior acute bleeding control compared to nasal packing, particularly for anterior bleeding 1
• Studies demonstrate higher rates of acute bleeding control and earlier discharge with topical TXA versus traditional packing 1
• Especially effective in patients taking antiplatelet drugs (aspirin/clopidogrel) 1
• Can be applied topically or given orally, with topical application being more common for localized bleeding 1

Cautery

• Chemical or electrical cautery should be applied only to the active or suspected bleeding site after adequate local anesthesia (typically topical lidocaine or tetracaine) 1
• Provides definitive hemostasis for identified bleeding points 1
• Critical pitfall: Avoid bilateral cautery to minimize risk of septal perforation 1
• Excessively vigorous cautery can damage tissue and lead to rebleeding 1

Surgical Hemostatic Agents

When to Use Biologic Agents

• Reserve topical hemostatic agents for situations where electrocautery or sutures are not ideal or safe, including bleeding near vulnerable structures or diffuse bleeding from peritoneal/solid organ surfaces 2
• These are adjuncts only—always attempt control with sutures, clips, or electrosurgery first 2

Categories of Surgical Hemostatic Agents

Physical Agents 3, 4:

• Gelatin-based products (absorb blood and provide mechanical matrix)
• Microfibrillar collagen (activates platelet aggregation)
• Oxidized regenerated cellulose (provides physical barrier and acidic environment)

Biologic/Physiologic Agents 3, 4, 5:

• Fibrin sealants (mimic final stages of coagulation cascade)
• Thrombin preparations (directly convert fibrinogen to fibrin)
• These activate the body's natural coagulation mechanisms

Caustic Agents 6:

• Aluminum chloride, ferric subsulfate (induce protein coagulation and vessel occlusion)
• Primarily used in dermatologic procedures for small vessel bleeding 6

Preventive Measures

Emollients and Humidification

• Intranasal emollients and humidification prevent rebleeding but do not stop active hemorrhage 1
• Apply petroleum-based ointments to keep nasal mucosa moist 1
• Well-tolerated with minimal risk except possible bleeding during application 1
• Cost-effective, noninvasive strategy for preventing recurrence 1

Clinical Decision Algorithm

1. Active bleeding present?

   • Yes → Apply topical vasoconstrictor (oxymetazoline) OR topical TXA for immediate control 1
   • Identify bleeding source while vasoconstrictor takes effect 1

2. Bleeding source identified?

   • Yes → Anesthetize and perform cautery to specific site 1
   • No → Continue pressure and vasoconstrictor application 1

3. Surgical setting with diffuse bleeding?

   • Use biologic hemostatic agents (fibrin, thrombin, gelatin, collagen, cellulose) when electrocautery/sutures unsafe 2, 3, 4
   • Select agent based on bleeding type and surgical field 3

4. After bleeding controlled:

   • Initiate emollient application and humidification to prevent recurrence 1
   • Avoid nasal trauma (picking, rubbing) 1

Key Contraindications and Risks

• Vasoconstrictor overuse leads to rebound congestion and medication dependence 1
• Bilateral cautery significantly increases septal perforation risk 1
• Topical hemostatic agents carry risks of allergic reactions and should not substitute for proper surgical technique 2, 4
• Understanding appropriate indications and contraindications is essential for optimal patient outcomes 2